Company Overview
AKEBIA THERAPEUTICS, INC.
AKBARevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
236M
2025 FY
Net Income
-5M
2025 FY
Shares Outstanding
257M
2025 FY
EPS
-0.02USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1517022
Exchange
Nasdaq
Location
US